Maternal stress, HPA activity, and fetal/infant outcome

Annals of the New York Academy of Sciences

Volumn 814, Issue , 1997, Pages 266-275

  Sandman, Curt A ^a,d   Wadhwa, Pathik D ^b   Chicz DeMet, Aleksandra ^a   Dunkel Schetter, Christine ^c   Porto, Manuel ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Fairview Developmental Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN; HYDROCORTISONE;

BIRTH WEIGHT; CONFERENCE PAPER; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; DELIVERY; FEMALE; FETUS; FETUS OUTCOME; GESTATIONAL AGE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LABOR; LEARNING; MENTAL STRESS; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NORMAL HUMAN; POSTNATAL DEVELOPMENT; PREGNANCY; PREMATURE LABOR; PRENATAL DEVELOPMENT; RISK; THIRD TRIMESTER PREGNANCY;

EID: 0030947348     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb46162.x     Document Type: Conference Paper

References (41)

1. BREIER, A. 1989. Experimental approaches to human stress research: Assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients. Biol. Psychiatry 26: 438-462.
2. JACOBSON, B., G. EKLUND, L. HANBERGER, D. LINNARSSON, G. SEDVALL & M. VALVERIUS. 1987. Perinatal origin of adult self-destructive behavior. Acta Psychiatr. Scand. 76: 364-371.
3. SANDMAN, C. A., P. C. DATTA, J. L. BARRON-QUINN, F. K. HOEHLER, C. WILLIAMS & J. M. SWANSON. 1983. Naloxone attenuates self-abusive behavior in developmentally disabled clients. Appl. Res. Ment. Retard. 4: 5-11.
4. SANDMAN, C. A., J. L. BARRON & H. COLMAN. 1990. An orally administered opiate blocker, Naltrexone, attenuates self-injurious behavior. Am. J. Ment. Retard. 95: 93-102.
5. SANDMAN, C. A., W. P. HETRICK, D. V. TAYLOR, J. L. BARRON, P. TOUCHETTE, I. LOTT, F. CRINELLA & V. MARINAZZI. 1993. Naltrexone reduces self-injury and improves learning. Exp. Clin. Psychopharmacol. 1: 242-258.
6. THOMPSON, T., T. HACKENBERG, D. CERUTTI, D. BAKER & S. AXTELL. 1994. Opioid antagonist effects on self-injury in adults with mental retardation: Response form and location as determinants of medication effects. Am. J. Ment. Retard. 99: 85-102.
7. BARRON, J. L. & C. A. SANDMAN. 1983. The relationship of sedative-hypnotic response to self-injurious behavior and stereotypy in mentally retarded clients. Am. J. Ment. Retard. 88: 177-186.
8. BARRON, J. L. & C. A. SANDMAN. 1985. Paradoxical excitement to sedative-hypnotics in mentally retarded clients. Am. J. Ment. Defic. 2: 124-129.
9. INSEL, T. R., G. M. KUISLEY, P. E. MAM & R. S. BRIDGES. 1990. Preterm stress has long-term effects on brain opiate receptors. Brain Res. 511: 93-97.
10. SANCHEZ, M. D., M. V. VILARES, T. FUENTE & M. LAORDEN. 1993. The β-endorphin response to prenatal stress during postnatal development in the rat. Brain Res. Dev. 74: 142-145.
11. CHERNICK, V. & R. J. CRIAG. 1982. Naloxone reverses neonatal depression caused by fetal asphyxia. Science 212: 252-253.
12. SANDMAN, C. A. & N. YESSAIAN. 1986. Persisting subsensitivity of the striatal dopamine system after fetal exposure to β-endorphin. Life Sci. 39: 1755-1763.
13. SANDMAN, C. A. & A. J. KASTIN. 1981. The influence of fragments of the LPH chain on learning, memory and attention in animals and man. Pharmacol. Ther. 13: 39-60.
14. BECKWITH, B. E., C. A. SANDMAN, D. HOTHERSALL & A. J. KASTIN. 1977. The influence of neonatal injections of α-MSH on learning, memory and attention in rats. Physiol. Behav. 18: 63-71.
15. STRAND, F. L., A. C. SEGARRA, C. A. ZUCCARELLI, J. KUME & K. J. ROSE. 1990. Neuropeptides as neuronal growth regulating factors: Peripheral nerve regeneration and the development of sexually dimorphic and motor behavior. Ann. N.Y. Acad. Sci. 579: 68-90.
16. ALVES, S. E., H. M. AKBARI, G. M. ANDERSON, E. C. AZMITIA, B. C. MCEWEN & F. L. STRAND. 1997. Neonatal ACTH administration elicits long-term changes in forebrain monoamine innervation: Subsequent disruptions in hypothalamic-pituitary-adrenal and gonadal function. Ann. N.Y. Acad. Sci. This volume.
17. WILLIAMS, M. T., M. B. HENNESSY & H. N. DAVIS. 1995. CRH administered to pregnant rats alters offspring behaviorand morphology. Pharmacol. Biochem. Behav. 52: 161-167.
18. JONES, S. A., A. N. BROOKS & J. R. CHALLIS. 1989. Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta. J. Clin. Endocrinol. Metab. 68: 825-830.
19. PETRAGLIA, F., L. AGUZZOLI, P. FLORIO, P. BAUMANN, A. D. GENAZZANI, C. DICARLO & R. ROMERO. 1995. Maternal plasma and placental immunoreactive corticotrophin-releasing factor concentrations in infection-associated term and pre-term delivery. Placenta 16: 157-164.
20. LOWRY, P. J. 1993. Corticotropin-releasing factor and its binding protein in human plasma. Ciba Found. Symp. 172: 108-115.
21. MCLEAN, M., A. BISITS, J. DAVIES, R. WOODS, P. LOWRY & R. SMITH. 1995. A placental clock controlling the length of human pregnancy. Nature Med. 1: 460-463.
22. LINTON, E. A., A. V. PERKINS, R. J. WOODS, F. EBEN, C. D. WOLFE, D. P. BEHAN, E. POTTER, W. W. VALE & P. J. LOWRY. 1993. Corticotropin releasing hormone-binding protein (CRH-BP): Plasma levels decrease during the third trimester of normal human pregnancy. J. Clin. Endocrinol. Metab. 76: 260-262.
23. PETRAGLIA, F., A. VOLPE, A. R. GENAZZANI, J. RIVIER, P. E. SAWCHENKO & W. VALE. 1990. Neuroendocrinology of the human placenta. Front. Neuroendocrinol. 11: 6-37.
24. PETRAGLIA, F., A. GALLINELLI, D. DEVITA, K. LEWIS, L. MATHEWS & W. VALE. 1994. Activin at parturition: Changes of maternal serum levels and evidence for binding sites in placenta and fetal membranes. Obstet. Gynecol. 84: 278-282.
25. ROBINSON, B. G., E. L. EMANUEL, D, M. FRIM & J. A. MAJZOUB. 1988. Glucocorticoid stimulation expression of corticotropin-releasing hormone gene in human placenta. Proc. Natl. Acad. Sci. USA 85: 5244-5248.
26. SANDMAN, C. A., P. D. WADHWA, W. P. HETRICK, M. PORTO & H. V. S. PEEKE. Human fetal heart rate dishabituation at 32 weeks gestation. Child Dev. In press.
27. WADHWA, P. D., C. A. SANDMAN, M. PORTO, C. DUNKEL-SCHETTER & T. J. GARITE. 1993. The association between prenatal stress and infant birthweight and gestational age at birth: A prospective investigation. Am. J. Obstet. Gynecol. 169: 858-865.
28. LOBEL, M., C. DUNKEL-SCHETTER & S. C. M. SCRIMSHAW. 1992. Prenatal maternal stress and prematurity: A prospective study of socioeconomically disadvantaged women. Health Psychol. 11: 32-40.
29. HEDEGAARD, M., T. B. HENRIKSEN, S. SABROE & N. J. SECHER. 1993. Psychological distress in pregnancy and preterm delivery. Br. Med. J. 307: 234-239.
30. CLIVER, S. P., R. L. GOLDENBURG, G. R. CUTTER, H. J. HOFFMAN, R. L. COPPER, S. J. GOTLIEB & R. O. DAVIS. 1992. The relationships among psychosocial profile, maternal size, and smoking in predicting fetal growth retardation. Obstet. Gynecol. 80: 262-267.
31. WILLIAMSON, H. A., M. LEFEVRE & M. HECTOR. 1989. Association between life stress and serious perinatal complications. J. Fam. Pract. 29: 489-496.
32. WADHWA, P. D., C. DUNKEL-SCHETTER, A. CHICZ-DEMET, M. PORTO & C. A. SANDMAN. The association between prenatal psychosocial factors and the maternal neuroendocrine axis in human pregnancy. Psychosom. Med. In press.
33. AXELROD, J. & T. D. REISINE. 1984. Stress hormones: Their interaction and regulation. Science 224: 452-459.
34. HERBERT, T. B. & S. COHEN. 1993. Stress and immunity in humans: A meta-analytic review. Psychosom. Med. 55: 364-379.
35. UR, E. 1991. Psychological aspects of hypothalamo-pituitary-adrenal activity. Ballieres Clin. Endocrinol. Metab. 5: 79-96.
36. CAMPBELL, E. A., E. A. LINTON, C. D. WOLFE, P. R. SCRAGGS, M. T. JONES & P. J. LOWRY. 1987. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J. Clin. Endocrinol. Metab. 64: 1054-1959.
37. KURKI, T., T. LAATIKAINEN, K. SALMINEN-LAPPALAINEN & O. YLIKORKALA. 1991. Maternal plasma corticotrophin-releasing hormone - Elevated in preterm labour but unaffected by indomethacin or nylidrin. Br. J. Obstet. Gynaecol. 98: 685-691.
38. WARREN, W. B., S. L. PATRICK & R. S. GOLAND. 1992. Elevated maternal and plasma corticotropin-releasing hormone levels in pregnancies complicated by preterm labor. Am. J. Obstet. Gynecol. 166: 1198-1207.
39. WOLFE, C. D. A., S. P. PATEL, E. A. LINTON, E. A. CAMPBELL, J. ANDERSON, A. DORNHORST, P. J. LOWRY & M. T. JONES. 1988. Plasma corticotrophin-releasing factor (CRH) in abnormal pregnancy. Br. J. Obstet. Gynecol. 95: 1003-1006.
40. THOMPSON, R. F. & P. M. GROVES. 1970. Habituation: A dual-process theory. Psychol. Rev. 77: 419-450.
41. MACKINTOSH, N. J. 1987. Neurobiology, psychology and habituation. Behav. Res. Ther. 25: 81-97.